FIELD: medicine, pharmacy. SUBSTANCE: invention relates to carbamazepin-base preparations showing the expressed anticonvulsant (antiepileptic) and in a moderate degree antidepressant (thymoleptic) and normotonic effect. Invention proposes an agent made as a tablet that comprises carbamazepin as an active component, starch, magnesium stearate and microcrystalline cellulose, polyvinylpyrrolidone as special additions and agent comprises additionally a cross-linked homopolymer of N-vinyl-2-pyrrolidone with nitrogen content 11-12.8% taken in the amount given in the invention claim. Invention provides the development of a simple available form of drug as a tablet containing carbamazepin as an active component. EFFECT: enhanced strength of tablet and its simultaneous rapid decomposition in water. 1 tbl
Authors
Dates
2002-09-20—Published
2001-09-14—Filed